Index of reports
> Hospitalization (961)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 961 Next >>
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-27
Patient: female, weighing 67.6 kg (148.7 pounds)
Reactions: Nodule, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 90 mg, unk, 1 hr infusion on d2,d4,d6,d8,d10
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-01
Cytarabine
Dosage: 1.80 g, unk,continuous infusion d1 to d10
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-30
Idarubicin HCL
Dosage: 48 mg, unk, on d1,d3,d5
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-30
Other drugs received by patient: Fluconazole; Valaciclovir; Ceftazidime; Oxazepam; Leucoplenin
Possible Cytarabine side effects in 10 year old male
Reported by a physician from United States on 2012-08-27
Patient: 10 year old male, weighing 76.1 kg (167.4 pounds)
Reactions: Hypersensitivity, Hyperglycaemia, Peripheral Motor Neuropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-06
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-05-22
PEG-Asparaginase
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Other drugs received by patient: Radiation
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-27
Patient: male, weighing 87.0 kg (191.4 pounds)
Reactions: Hepatic Function Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-05-16
Cytarabine
Start date: 2012-05-16
Daunorubicin HCL
Start date: 2012-05-16
Daunorubicin HCL
Start date: 2012-05-16
Revlimid
Administration route: Oral
Start date: 2012-05-16
End date: 2012-05-31
Other drugs received by patient: Fluconazole; Ciprofloxacin HCL
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 95.8 kg (210.8 pounds)
Reactions: Abdominal Pain, Hypotension, Pancytopenia, Ascites, Faecaloma, Diarrhoea, Sepsis, Colitis, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 25 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Clofarabine
Dosage: 25 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Cytarabine
Dosage: 750 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Cytarabine
Dosage: 750 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-02
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-01
Other drugs received by patient: Vancomycin; Metronidazole; Piritramide; Enoxaparin Sodium; Zofran; Clonazepam; Sodium Chloride; Ciprofloxacin; Acyclovir; Ringer; Levothyroxine Sodium; Potassium Chloride; Ceftazidime; Noxafil
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 48.0 kg (105.6 pounds)
Reactions: Memory Impairment
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amphotericin B
Dosage: 6x60 mg/d
Administration route: Oral
Start date: 2012-06-24
Cytarabine
Dosage: 110 mg, per day
Start date: 2012-08-08
End date: 2012-08-11
Cytarabine
Dosage: 110 mg, per day
Start date: 2012-08-16
Furosemide
Dosage: 2x10mg/d
Start date: 2012-08-09
End date: 2012-08-11
Granisetron
Dosage: 3 mg, per day
Start date: 2012-08-08
End date: 2012-08-11
Granisetron
Dosage: 3 mg, per day
Start date: 2012-08-16
Imatinib Mesylate
Dosage: 450 mg, per day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-13
Mercaptopurine
Dosage: 1x87.5mg/d average
Administration route: Oral
Start date: 2012-08-06
Pantoprazole
Dosage: 40 mg, per day
Administration route: Oral
Start date: 2012-06-24
End date: 2012-08-15
Sulfamethoxazole and Trimethoprim
Dosage: 2x120mg every sat, sun and mon
Administration route: Oral
Possible Cytarabine side effects in 17 year old male
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)
Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-28
Cytarabine
Dosage: unk
Start date: 2012-05-18
End date: 2012-05-18
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-26
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Dyspnoea, Tachycardia, Atrial Fibrillation, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1470 mg
Start date: 2012-08-10
Daunorubicin HCL
Dosage: 570 mg
End date: 2012-08-06
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-23
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-21
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-17
End date: 2012-07-20
Dasatinib
Dosage: 40 milligram daily;
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-29
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-13
End date: 2012-07-21
Other drugs received by patient: Zofran; Miralax
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Pain in Extremity, Hypotension, Splenic Infarction, Paraesthesia, Septic Embolus, Fungal Test Positive, Hypoxia, Circulatory Collapse, Asthenia, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, intrathecal
End date: 2012-07-12
Daunorubicin HCL
Dosage: 200 mg
End date: 2012-08-02
Methotrexate
Dosage: 30 m, intrathecal
End date: 2012-08-09
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 4900 iu, intravenous
End date: 2012-07-15
Prednisone
Dosage: 3360 mg, oral
Administration route: Oral
End date: 2012-08-08
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-22
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Confusional State, Hepatic Enzyme Abnormal, Disorientation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 57 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-06
Cytarabine
Dosage: 360 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-28
Etoposide
Dosage: 212 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-28
Methotrexate
Dosage: 900 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-31
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-08-06
Prednisolone
Dosage: 55 mg, bid
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-06
Other drugs received by patient: Esomeprazole Sodium; Oxazepam; Fluconazole
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-22
Patient: female, weighing 23.6 kg (51.9 pounds)
Reactions: Activated Partial Thromboplastin Time Prolonged, Blood Fibrinogen Decreased, RED Blood Cell Schistocytes Present, Fibrin D Dimer Increased, International Normalised Ratio Increased, Coagulopathy, Prothrombin Time Prolonged
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg
Daunorubicin HCL
Dosage: 46 mg
Dexamethasone
Dosage: 115 mg
Methotrexate
Dosage: 12 mg
PEG-L Asparaginase (Pegaspargase, Oncospar)
Vincristine Sulfate
Dosage: 2.8 mg
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-21
Patient: male, weighing 13.6 kg (29.9 pounds)
Reactions: Contusion, Vomiting, Flatulence, Hypotension, Tachycardia, Gastrointestinal Necrosis, Cardio-Respiratory Arrest, Hypophagia, Abdominal Distension, Bacterial Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: it 2-2.99 yrs 50 mg
Dexamethasone TAB
Dosage: po 3 mg/m2 dose (1.75 bid)
Administration route: Oral
Methotrexate Sodium
Dosage: it 2 mg/m2
PEG-L Asparaginase (Pegaspaegase, Oncospar)
Dosage: iv 2500 units/m2
Vincristine
Dosage: iv 1.5mg/m2 on day 1 and day 8
Possible Cytarabine side effects in 14 year old male
Reported by a physician from Norway on 2012-08-21
Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Mucosal Inflammation, Listless, Fatigue, Febrile Neutropenia, Sinusitis, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Celecoxib
Dosage: 400 mg, 2x/day
Indication: Medulloblastoma
Cytarabine
Dosage: 50 mg, cyclic, every other month
Cytarabine
Dosage: 50 mg, cyclic, every other week then monthly
Indication: Medulloblastoma
Etoposide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Thalidomide
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Other drugs received by patient: Prednisolone Succinate
Possible Cytarabine side effects in male
Reported by a physician from United Kingdom on 2012-08-21
Patient: male, weighing 80.9 kg (178.0 pounds)
Reactions: Lower Gastrointestinal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-08-09
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-08-09
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-08-08
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-08-08
Other drugs received by patient: Perindopril Erbumine; Aspirin; Persantine
Possible Cytarabine side effects in 8 year old female
Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-08-21
Patient: 8 year old female
Reactions: Mucoepidermoid Carcinoma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Elspar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Prednisone TAB
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-08-20
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Pericarditis, Cerebral Artery Embolism, Respiratory Failure, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin
Possible Cytarabine side effects in 14 year old male
Reported by a physician from United States on 2012-08-20
Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Dyspnoea, Hypotension, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-10
Cytarabine
Dosage: 70 mg, cyclic
Start date: 2012-08-09
End date: 2012-08-09
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-17
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Dyspnoea, Vomiting, Nausea, Hyperreflexia, Encephalopathy, Extensor Plantar Response, Endophthalmitis, Lung Consolidation, Respiratory Failure, Emotional Disorder, CSF Pressure Increased, Reflexes Abnormal, Lethargy
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Amsacrine
Dosage: 220 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-28
Clofarabine
Dosage: 18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Cytarabine
Dosage: 3600 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Other drugs received by patient: Valaciclovir
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-17
Patient: male, weighing 31.5 kg (69.3 pounds)
Reactions: Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-06
PEG-Asparaginase
Indication: T-Cell Type Acute Leukaemia
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Other drugs received by patient: Radiation
Possible Cytarabine side effects in 63 year old female
Reported by a physician from Germany on 2012-08-17
Patient: 63 year old female, weighing 49.0 kg (107.8 pounds)
Reactions: Pneumonia Cryptococcal, Cardiac Failure, Mitral Valve Incompetence, Bone Marrow Failure, Acute Myocardial Infarction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: sequential high dose, sham regimen, within amlcg-2008 study
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: sequential high dose, sham regimen, within amlcg-2008 study
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in 66 year old male
Reported by a physician from United Kingdom on 2012-08-17
Patient: 66 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Multi-Organ Failure, Neutropenic Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2007-09-20
End date: 2007-09-22
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2007-09-20
End date: 2007-09-22
Mylotarg
Dosage: 5.3 mg (total dose)
Indication: Acute Myeloid Leukaemia
Start date: 2007-09-20
End date: 2007-09-22
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-08-17
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 2050 mg, qd, days 8-10
Start date: 2012-04-26
End date: 2012-04-28
Cytarabine
Dosage: 1050 mg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Daunorubicin HCL
Dosage: 125 mg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Granocyte
Dosage: 410 mcg, qd, days 1-10
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-28
Mozobil
Dosage: 240 mcg/kg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Mozobil
Dosage: 240 mcg/kg, qd, days 8-10
Start date: 2012-04-26
End date: 2012-04-28
Mozobil
Possible Cytarabine side effects in 44 year old male
Reported by a physician from Germany on 2012-08-17
Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-12
Etoposide
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-08
Gemtuzumab Ozogamicin
Dosage: 6 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-08
End date: 2012-06-08
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-10
End date: 2012-06-10
Idarubicin HCL
Dosage: 24 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Tretinoin
Dosage: 90 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-11
End date: 2012-06-12
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-13
End date: 2012-06-16
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-21
End date: 2012-06-21
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-08-17
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Rash Generalised, Acute Myeloid Leukaemia, Febrile Bone Marrow Aplasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ccnu
Administration route: Oral
Start date: 2012-04-18
End date: 2012-04-18
Cytarabine
Start date: 2012-04-18
End date: 2012-04-24
Idarubicin HCL
Start date: 2012-04-18
End date: 2012-04-22
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-04-18
End date: 2012-06-28
Vidaza
Dosage: 1330 milligram
Start date: 2012-04-18
End date: 2012-04-24
Other drugs received by patient: Rocephin; Amikacin; Bisoprolol Fumarate
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-16
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: Bronchopulmonary Aspergillosis, Dyspnoea, Respiratory Failure, Sepsis, Hepatic Lesion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 18.48 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Cytarabine
Dosage: 369.66 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Idarubicin HCL
Dosage: 22.18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Other drugs received by patient: Piperacillin W
Possible Cytarabine side effects in 51 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: 51 year old male, weighing 65.4 kg (143.9 pounds)
Reactions: Pseudomonas Infection, Thrombophlebitis, Device Related Infection, Pulmonary Cavitation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Cytarabine
Dosage: 5.64 g with 500 ml of 0.9 % nacl infused over 2 hours at 250 ml/hr
Indication: Mantle Cell Lymphoma
Start date: 2012-07-06
End date: 2012-07-07
Dexamethasone Sodium Phosphate
Dosage: unk
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Indication: Mantle Cell Lymphoma
Start date: 2012-06-06
End date: 2012-06-11
Doxorubicin HCL
Start date: 2012-07-04
Fluconazole
Indication: Mantle Cell Lymphoma
Start date: 2012-07-04
Methotrexate
Dosage: 1504 mg in 250 ml of nacl 0.9 % infused over 22 hours at 11.3636 ml/hr
Start date: 2012-07-06
Methotrexate
Dosage: 376 mg with 250 ml of 0.9 % sodium chloride, infuse over 2 hours
Indication: Mantle Cell Lymphoma
Start date: 2012-07-05
End date: 2012-07-05
Neulasta
Indication: Mantle Cell Lymphoma
Start date: 2012-07-10
Rasburicase
Dosage: 100 ml/hr for 15 min then 100 ml/hr for 30 min then increased to 400 ml/hr
Indication: Mantle Cell Lymphoma
Start date: 2012-07-03
Rituximab
Indication: Mantle Cell Lymphoma
Start date: 2012-06-06
End date: 2012-06-11
Rituximab
Dosage: 375 mg/m2, unk
Velcade
Indication: Mantle Cell Lymphoma
Start date: 2012-07-04
Vincristine
Indication: Mantle Cell Lymphoma
Other drugs received by patient: RED Blood Cells; Pantoprazole; Diphenhydramine Hydrochloride; Sodium Bicarbonate; Hydrocortisone; Haloperidol; Benadryl; Acetaminophen; Mesna; Ceftazidime; Voriconazole; Acetaminophen; Xanax; Oxycodone; Vicodin; Tylenol; Zolpidem; Meperidine HCL; Acetaminophen; Valtrex; RED Blood Cells; Ondansetron; Lorazepam; Ciprofloxacin; Diphenhydramine Hydrochloride; Leucovorin Calcium; Rituxan; Meropenem; Hydrocortisone
Possible Cytarabine side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-16
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Dyspnoea, Tachycardia, Atrial Fibrillation, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1470 mg
End date: 2012-08-10
Daunorubicin HCL
Dosage: 570 mg
End date: 2012-08-06
Page 1 Next >>
|